{
  "id": 12765958,
  "title": "Hinge Health CEO Daniel Perez sells over $410k in company stock",
  "url": "https://urgent.news/2026/10/08/hinge-health-ceo-daniel-perez-sells-over-410k-in-company-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-08T02:31:15.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/hinge-health-ceo-daniel-perez-sells-over-410k-in-company-stock-93CH-4937829"
  },
  "original_language": "en",
  "account": "On October 6, 2026, Daniel Antonio Perez, the CEO and co-founder of Hinge Health Inc. (NASDAQ:HNGE), sold 4,100 shares of the company's Class A Common Stock. The sale was executed under a Rule 10b5-1 trading plan, adopted by Perez and his spouse on June 11, 2026. The shares were sold within a narrow price range of $100.05 to $100.26, with an average cost of $100.1978 per share. This transaction took place as the stock was trading near its 52-week high of $100.36, following a significant increase of 156% over the past six months. Prior to selling, Perez had acquired 4,100 shares of Class A Common Stock, which were subsequently converted from Class B Common Stock. As a result of these transactions, Perez currently holds no Class A Common Stock, retaining 9,774,572 shares of Class B Common Stock. His spouse indirectly owns 35,470 shares of Class A Common Stock and 208,445 shares of Class B Common Stock, excluding 3,777,002 performance-based restricted stock units held by Perez. The insider sale occurs as Hinge Health, valued at $7.9 billion, is reportedly overvalued according to InvestingPro analysis. Analysts have shown positive sentiment towards the company, with Truist Securities raising its price target to $112, citing improved financial projections following its second-quarter earnings and a pending acquisition. Stifel increased its price target to $115, while BofA Securities initiated coverage with a Buy rating and a price target of $110.",
  "summary": null,
  "key_points": [
    "CEO Daniel Perez sold $410k of Hinge Health stock on Oct 6, 2026",
    "Sale under Rule 10b5-1 plan, price $100.05-$100.26 per share",
    "Perez now holds no Class A shares, 9.77M Class B shares"
  ],
  "editors_take": "The CEO's sale of over $410,000 worth of Hinge Health stock, executed under a pre-set trading plan, removes him from holding any Class A Common Stock, potentially signalling a shift in his investment strategy.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Starbucks international CEO sells $155,501 in company stock",
        "url": "https://urgent.news/2026/10/07/starbucks-international-ceo-sells-155-501-in-company-stock",
        "published": "2026-10-07T23:16:21.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}